-
Mashup Score: 20Small Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Embolization for Gastric Varices: A Multicenter Cohort Study - 4 day(s) ago
The effect of transjugular intrahepatic portosystemic shunt (TIPS) plus variceal embolization for treating gastric varices (GVs) remains controversial. This nationwide multicenter cohort study aimed to evaluate whether adding variceal embolization to a small diameter (8-mm) TIPS could reduce the rebleeding incidence in patients with different types of GVs.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 6Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis - 9 day(s) ago
Few data compare topical corticosteroid (tCS) dosing regimens and outcomes. We aimed to compare treatment outcomes in patients with eosinophilic esophagitis (EoE) by once or twice daily dosing regimens.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
#ICYMI, EoE outcomes did not differ by daily or twice daily dosing regimens. These results inform tCS dosing regimens and reassure that both are effective: 🔗 https://t.co/PbHoG2MxYS
-
-
Mashup Score: 0
Login with your AGA username and password. Editorial Office: AGA Institute 4930 Del Ray Avenue Bethesda, Maryland 20814-3015 E-mail: [email protected] Phone: 301-654-2055 Clinical Gastroenterology and Hepatology (CGH) publishes clinical articles on all aspects of the digestive system, including the liver and pancreas. The types of articles CGH publishes include original papers, review articles, and special category manuscripts. Manuscripts must be prepared in accordance with the “Uniform Requirements for
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
@AmerGastroAssn ➡️ For more information about the formatting requirements for initial and revised submissions, please visit our Guide for Authors: https://t.co/tESk6d3S3C
-
-
Mashup Score: 8
The purpose of this American Gastroenterological Association Institute Clinical Practice Update is to review the available evidence for diagnosing and treating, as well as examine opportunities for future research in, sclerosing mesenteritis.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
Don't miss May's Clinical Practice Update on sclerosing mesenteritis ➡️ https://t.co/NwPfnoumZN @AmerGastroAssn https://t.co/gS470rYVXQ
-
-
Mashup Score: 15Perianal Fistulizing Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care - 13 day(s) ago
Perianal fistulation is a challenging phenotype of Crohn’s disease, with significant impact on quality of life. Historically, fistulae have been classified anatomically in relation to the sphincter complex, and management guidelines have been generalized, with lack of attention to the clinical heterogenicity seen. The recent ‘TOpClass classification system’ for perianal fistulizing Crohn’s disease (PFCD) addresses this issue, and classifies patients into defined groups, which provide a focus for fistula management that aligns with disease characteristics and patient goals.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
Editors Essential Reading ▶️ Perianal Fistulizing #Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care: https://t.co/gjH3Tk9QFM https://t.co/EqqIWCspZX
-
-
Mashup Score: 7Impact of Time Period and Birth Cohort on the Trend of Advanced Neoplasm Prevalence in the 40–49 Average-Risk Screening Population - 23 day(s) ago
Early-onset colorectal cancer (CRC) is increasing globally. While the United States has lowered the age of initiation of screening to 45 years, other countries still start screening at 50 years of age. In Taiwan, the incidence of CRC has declined in 55- to 74-year-olds after the initiation of screening, but still increased in those 50–54 years of age, potentially due to the rising precancerous lesion incidence in 40- to 49-year-olds. This study aimed to explore the chronological trend of the prevalence of colorectal advanced neoplasms (AN) in the screening population 40–54 years of age.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
📖 This #CGH article, relevant to #CRC screening, was featured in Medical Xpress: https://t.co/p8VLpLA60Y 🔗 Read the highlight here: https://t.co/vcHH4Rhpqu @medical_xpress https://t.co/HwWb47AEDL
-
-
Mashup Score: 15Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes - 25 day(s) ago
Glucagon-like peptide-1–receptor agonists (GLP1-RAs) have been associated with greater retention of gastric contents, however, there is minimal controlled, population-based data evaluating the potential adverse effects of GLP1-RA in the periprocedural setting. We aimed to determine if there is increased risk of aspiration and aspiration-related complications after upper endoscopy in patients using GLP1-RAs.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes ➡️ https://t.co/DgJ4pcxinE https://t.co/7W7rmXjwWC
-
-
Mashup Score: 24Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on Biologics - 27 day(s) ago
Biologic therapies in the context of inflammatory bowel disease and pregnancy lead to improved maternal and fetal outcomes. Placental transfer results in detectable drug concentrations in infants. Rotavirus infection results in diarrheal related hospitalizations; however, the live oral vaccine is not currently recommended in biologic exposed infants. The aim of this study was to assess the effect of maternal biologic therapies on the infant immune system and safety of live rotavirus vaccination in biologic-exposed infants.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
Live rotavirus vaccination was provided after immune profile and assessment to infants born to mothers with IBD on biologics and appears to be safe despite infant detectable mAb concentration: https://t.co/KDQIP9Nji1 @SeowCynthia @RPanaccione @kennethernest https://t.co/Mh0LEDXL3S
-
-
Mashup Score: 15IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab - 30 day(s) ago
Short-term mortality in alcohol-related hepatitis (AH) is high, and no current therapy results in durable benefit. A role for interleukin (IL)-1β has been demonstrated in the pathogenesis of alcohol-induced steatohepatitis. This study explored the safety and efficacy of canakinumab (CAN), a monoclonal antibody targeting IL-1β, in the treatment of patients with AH.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
👋 IL-1 Signal Inhibition in Alcohol-Related #Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab: https://t.co/WS8WXDHySv https://t.co/052m3yRL4z
-
-
Mashup Score: 3Biopsy Proteome Score Performs Well as an Effect Measure in a Gluten Challenge Trial of Celiac Disease - 1 month(s) ago
Development of novel treatments for celiac disease is dependent on precise tools to monitor changes in gluten-induced mucosal damage. Current histology measures are subjective and difficult to standardize. Biopsy proteome scoring is an objective alternative to histology which is based on robust changes in biological pathways that directly reflect gluten-induced mucosal damage. In this study, we aimed to evaluate biopsy proteome scoring as an effect measure in a clinical trial setting by measuring intestinal remodeling in response to oral gluten challenge.
Source: www.cghjournal.orgCategories: General Medicine News, GastroenterologyTweet-
Biopsy proteome scoring can serve as an effective measure of gut disease state following oral gluten challenge in celiac disease: https://t.co/qEOD8wW7HH @stamnaes https://t.co/8uAiHS9lYU
-
👋 These findings suggest that patients with GOV2 and IGV1, rather than GOV1, could benefit from embolization with TIPS: https://t.co/mnsTz3Y6Ww https://t.co/YTuwZfMqEA